| Application no. and date | 13168383.1 (espacenet) (Federated) (European Patent Register), 20070807 | | Patent/reg. no. and date | DK/EP 2641601, 20160706 | | Publication date | 20130925 | | Priority no. and date | US 836185 P, 20060807, US 944262 P, 20070615 | | EP pub. no. and date |
EP 2641601 20130925 | | Effective date | | | Applicant/owner | AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard
Redwood City, CA 94063, US,
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, MA 02215, US | | Applicant ref. no. | P59101dk01 | | Inventor | AFAR, Daniel, 2882 Arlington Place
Fremont, California 94555, US,
Andersen, Kenneth C., 264 Weston Road
Wellesley, Massachusetts 02482, US,
Tai, Yu-Tzu, 22 Olde Filed road
Newton, Massachusetts 02459, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 31/573 (2006.01) , A61K 31/69 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Fremgangsmåder til behandling af multipelt myelom under anvendelse af kombinationsterapi baseret på HuLuc63 med bortezomib | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
